Living donor liver transplantation from hepatitis C‐infected donor to hepatitis C‐infected recipient.

Living donor liver transplantation (LDLT) from HCV-positive donors into HCV-positive recipients is not established yet (1). We report a case of combining direct antiviral agents (DAA) therapy and living liver donation from a donor with chronic-HCV-infection (genotype 3a) to a recipient with congenital chronic-HCV-infection (genotype 3a).